MannKind | MNKD - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q3 Sep/2025 0.01 0.07 Nov/10
FY2026Q2 Jun/2026 -0.01 -0.01 0.05 Aug/05
FY2026Q1 Mar/2026 -0.02 -0.01 0.07 May/06
FY2025Q4 Dec/2025 0.01 0.01 0.08 Feb/26
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05




Eps تغيير تاريخ
Adma Biologics USD 0.19 0.01 2026-03
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Halozyme Therapeutics USD 2.28 0.68 2026-06
Insmed USD -0.06 0.7 2026-06
Karyopharm Therapeutics USD -1.02 1.2 2026-03
MacroGenics USD -0.58 0.36 2026-03
MannKind USD -0.01 0.01 2026-06
Merck USD -0.13 1.15 2026-06
Minerva Neurosciences USD -0.56 3.53 2024-12
Novavax USD 0.13 0.59 2025-12
Novo Nordisk DKK 0.96 9.95 2026-06
Pfizer USD 0.77 0.02 2026-06
Sanofi EUR 2.09 0.21 2026-06
Xencor USD -0.29 1.42 2026-06